Armistice Capital’s Bio-Path Holdings Inc BPTH Stock Holding History

Armistice Capital’s Portfolio BPTH Stock Details BPTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-237,561	Closed	-$276K	–	295
2024 Q4	$276K	Buy	+237,561	New	+$221K	﹤0.01%	187
2024 Q3	–	Sell	-97,000	Closed	-$194K	–	329
2024 Q2	$194K	Buy	+97,000	New	+$266K	﹤0.01%	212

Other funds holding BPTH

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Armistice Capital's BPTH Position: Q1 2025 in Review

Armistice Capital sold out of Bio-Path Holdings Inc (BPTH) in Q1 2025, closing a stake of 237,561 shares — an estimated $276K sold.

Armistice Capital first reported a position in BPTH in Q2 2024 and held it in 2 quarters. The position peaked at $276K in Q4 2024. 2 funds tracked by Wall St. Rank hold BPTH as of Q1 2025.

Armistice Capital reported no remaining Bio-Path Holdings Inc position as of Q1 2025 after selling out during the quarter.
Armistice Capital sold 237,561 Bio-Path Holdings Inc shares in Q1 2025, an estimated $276K.
Armistice Capital first reported a position in Bio-Path Holdings Inc in Q2 2024 and held it in 2 quarters.
Armistice Capital's Bio-Path Holdings Inc position peaked at $276K in Q4 2024.
2 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2025.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.